News

to keep you up to date

26 Apr 2021

New SDS Requirements

Starting 2021

Regulation (EU) 2020/878 updated REACH Annex II, which sets the requirements for the compilation of the Safety Data Sheets (SDS) within EEA. The main purpose of the update was to include in the SDS information on nanomaterials and on hazards related to endocrine disrupting properties, as well as to implement the requirements of the latest GHS version into the EU legislation. Newly prepared SDS have to comply with the regulation starting January 2021. SDS prepared before January 2021 have to be updated by 2023.

A summary of the main new data requirements is given below:

SECTION 1: Identification of the substance / mixture and of the company/undertaking

1.1 Product identifier: UFI for hazardous mixtures (mandatory only for unpacked goods)

SECTION 2: Hazards identification

2.3. Other hazards: Information on substances above 0,1% which are either

  • identified as having endocrine disrupting properties according to criteria in Biocidal Products Regulation or in Plant Protection Products Regulation or
  • placed on the Candidate List (SVHC) due to endocrine disrupting properties

SECTION 3: Composition/information on ingredients

3.1 Substances:

M-Factor
For substances with harmonised classification in Annex VI, CLP: Acute Toxicity Estimate (ATE)
For registered nanomaterials: particle characteristics

3.2 Mixtures:

Substances above 0,1% which are

  • identified as having endocrine disrupting properties according to criteria in Biocidal Products Regulation or in Plant Protection Products Regulation
  • placed on the Candidate List (SVHC) due to endocrine disrupting properties

Substances classified as skin sensitiser: from one tenth of the specific concentration limit

Substance related info: M-Factor, ATE, particle characteristics for nanoforms

SECTION 9: Physical and chemical properties

9.1. Information on basic physical and chemical properties: Additional explanations for various end points acc. GHS

SECTION 11: Toxicological information

11.2 Information on other hazards: For substances with endocrine disrupting properties, information on adverse health effects

SECTION 15: Regulatory information

15.1 Safety, health and environmental regulations/legislation specific for the substance or mixture: Specific provisions e.g. conditions included in REACH authorisations